Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair Thompson

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
JCO Precision Oncology|November 16, 2023
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination DeficiencyShane R Stecklein, William Barlow, Lajos Pusztai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, William E Barlow, et al.
British Journal of Cancer|August 19, 2021
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breastMaartje van Seijen, Esther H Lips, Liping Fu, et al.
JCO Precision Oncology|January 12, 2023
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast CancerAfroditi Nanou, Jieling Miao, Frank A W Coumans, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boostJayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Nature Communications|October 15, 2020
Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activationMarco Napoli, Xiaobo Li, Hayley D Ackerman, et al.
Nature|November 20, 2024
Normal breast tissues harbour rare populations of aneuploid epithelial cellsYiyun Lin, Junke Wang, Kaile Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2025
Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trialGiacomo Biganzoli, Edoardo Isnaldi, François Richard, et al.
Cancer Cell|May 6, 2008
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activatorSonia Lain, Jonathan J Hollick, Johanna Campbell, et al.
NPJ Breast Cancer|July 8, 2017
The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international groupMarion Maetens, David Brown, Alexandre Irrthum, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
JCO Precision Oncology|November 16, 2023
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination DeficiencyShane R Stecklein, William Barlow, Lajos Pusztai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, William E Barlow, et al.
British Journal of Cancer|August 19, 2021
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breastMaartje van Seijen, Esther H Lips, Liping Fu, et al.
JCO Precision Oncology|January 12, 2023
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast CancerAfroditi Nanou, Jieling Miao, Frank A W Coumans, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boostJayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Nature Communications|October 15, 2020
Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activationMarco Napoli, Xiaobo Li, Hayley D Ackerman, et al.
Nature|November 20, 2024
Normal breast tissues harbour rare populations of aneuploid epithelial cellsYiyun Lin, Junke Wang, Kaile Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2025
Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trialGiacomo Biganzoli, Edoardo Isnaldi, François Richard, et al.
Cancer Cell|May 6, 2008
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activatorSonia Lain, Jonathan J Hollick, Johanna Campbell, et al.
NPJ Breast Cancer|July 8, 2017
The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international groupMarion Maetens, David Brown, Alexandre Irrthum, et al.
Pageof 10